Personalised treatments designed to fight cancer while minimising side effects.
Gynaecological cancer refers to cancers that develop in a woman’s reproductive system. The main types are cervical, endometrial (uterine), ovarian, vulvar and vaginal cancers. Each type behaves differently, but all require early detection and personalised treatment for the best outcomes.
Gynaecological cancers include cancers of the cervix, ovaries, and uterus (endometrium/corpus uteri). In the Philippines, these cancers account for a meaningful share of the cancer burden among women.
According to the IARC Global Cancer Observatory (GLOBOCAN 2022):
These figures highlight the importance of prevention and early detection, including HPV vaccination and cervical screening, which are key strategies in the global effort to eliminate cervical cancer as a public health problem.
Symptoms vary depending on the cancer type, but warning signs may include:
Any abnormal bleeding after menopause should be checked promptly, as this can be an early sign of endometrial cancer.
Philippines has adopted primary HPV DNA testing as the national screening method for cervical cancer, replacing Pap smears. Women aged 30 to 65 years are advised to undergo HPV testing at recommended intervals. Self-sampling kits are also being introduced to make testing more accessible, especially in rural areas.
HPV vaccination is offered to all 13-year-old girls under the national immunisation programme, providing strong protection against cervical cancer.
For ovarian, endometrial, vulvar and vaginal cancers, there are currently no population-wide screening tests. Women should seek medical advice quickly if they notice abnormal symptoms, especially post-menopausal bleeding or persistent bloating.
The main causes and risk factors include:
Cancer limited to the organ of origin
Spread to nearby tissues
Spread to regional lymph nodes or pelvic structures
Distant spread to other organs such as liver, lung or bone
Treatment depends on the cancer type and stage. Options may include:
Supportive care such as nutrition counselling, fertility preservation, pain management, and psycho-oncology is integrated into treatment to improve quality of life.
Gynaecological cancers include cancers of the cervix, ovaries, and uterus (endometrium/corpus uteri). In the Philippines, these cancers account for a meaningful share of the cancer burden among women.
According to the IARC Global Cancer Observatory (GLOBOCAN 2022):
These figures highlight the importance of prevention and early detection, including HPV vaccination and cervical screening, which are key strategies in the global effort to eliminate cervical cancer as a public health problem.
At OncoCare Philippines, your care is supported by a multidisciplinary team of oncologists, gynaecologic surgeons, radiation specialists, radiologists, pathologists, oncology nurses, counsellors and allied health experts. Working together, they provide personalised treatment and holistic support for every patient.
